Loading component...
Publications
Read their latest work
Article
Milliman MedIntel Part D trend insights
15 January 2026 - by Madeleine Feller, Rachel W. Madden, Katherine M. Holcomb, Joey Robers
Drug costs for Medicare Part D participants rose 20% in 3Q 2025 versus 3Q 2024, driven by a 35% increase in costs in the non-low income market.